Method of inhibiting complement activation with human anti-factor C3 antibodies and use thereof

Details for Australian Patent Application No. 2008231092 (hide)

Owner NovelMed Therapeutics, Inc.

Inventors Bansal, Rekha

Agent Fisher Adams Kelly

Pub. Number AU-A-2008231092

PCT Pub. Number WO2008/118711

Priority 11/690,334 23.03.07 US

Filing date 19 March 2008

Wipo publication date 2 October 2008

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

29 October 2009 PCT application entered the National Phase

  PCT publication WO2008/118711 Priority application(s): WO2008/118711

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008231093-Coacervation process

2008231090-Ultrasonic surgical instrument blades